Safety of human plasma-derived clotting factor products and their role in haemostasis in patients with haemophilia: meeting report

Haemophilia. 2007 Sep;13(5):663-9. doi: 10.1111/j.1365-2516.2007.01481.x.
No abstract available

Publication types

  • Consensus Development Conference
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Coagulation Factors / adverse effects*
  • Disease Models, Animal
  • Drug Administration Schedule
  • Female
  • Hemophilia A / drug therapy*
  • Hemostasis / drug effects*
  • Humans
  • Infusions, Intravenous
  • Male
  • Recombinant Proteins / adverse effects
  • Treatment Outcome

Substances

  • Blood Coagulation Factors
  • Recombinant Proteins